We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies

Aro4.0

Aronia Research

Mostly mechanism / observationalHigh safety

4 peer-reviewed studies

What the evidence says

Mostly mechanism / observational

Most Aronia studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.

Most evidence is from medium-quality meta-analyses and randomised trials published 2016–2025 with a typical study size of 666 participants.

Based on 4 studies · 2 meta-analyses · 1 RCT · 704 total participants

Confidence

High

By outcome

Heart & blood pressurePossible small reductions in blood pressure and total cholesterol (older meta-analysis), but a rigorous 2025 meta found no significant overall effect · 6-12 weeks (inconsistent)
Mostly mechanism / observational3 studies
Glucose & metabolicA pooled analysis found a small blood-glucose reduction (-0.44 mmol/L); broader metabolic benefits are unproven · 6-12 weeks (inconsistent)
Too few graded studies1 study

Active research area

3 studies in the last 5 years · Latest meta-analysis: 2025

20162025

1Meta-Analysisn=666 · large study2025

Chokeberry supplementation did not significantly improve cardiometabolic outcomes in the general adult population.

Frumuzachi O, Mocan A, Rohn S, Gavrilaș L · Nutrients (2025)

10 RCTs, 666 participants; random-effects meta-analysis with GRADE and trial-sequential analysis
NO significant effect on cardiometabolic outcomes overall
Subgroup signals only: lower total/LDL cholesterol in those with baseline cholesterol <200 mg/dL, lower SBP with >50mg/day anthocyanin, raised fasting glucose in those ≤50 years

View source

2Systematic Review2022

Aronia did not influence body weight, lipids, or blood pressure, but a quantitative analysis revealed a mean reduction in blood glucose of 0.44 mmol/l.

Christiansen CB, Mellbye FB, Hermansen K, Jeppesen PB, Gregersen S · Rev Diabet Stud (2022)

17 studies reviewed; 4 suitable for quantitative analysis
No effect on body weight, triglycerides, total/HDL cholesterol, or blood pressure in pooled analysis
Beneficial mean blood-glucose reduction of 0.44 mmol/L (P=0.0001)

View source

3Meta-Analysis2021

Daily supplementation with aronia berry extracts for 6-8 weeks significantly reduces systolic blood pressure as well as total cholesterol.

Hawkins J, Hires C, Baker C, Keenan L, Bush M · J Diet Suppl (2021)

Meta-analysis of controlled trials of 6-8 weeks of aronia supplementation
Significant reduction in systolic blood pressure
Significant reduction in total cholesterol

View source

4Crossovern=38 · small study2016

Chokeberries decreased daytime blood pressure and low-grade inflammation in patients with mildly elevated blood pressure.

Loo BM, Erlund I, Koli R, Puukka P, Hellström J, et al. · Nutr Res (2016)

38 participants, 16-week single-blind crossover; chokeberry juice (300mL/d) + powder (3g/d) vs placebo
Daytime ambulatory diastolic BP fell -1.64 mmHg (P=0.02); awake systolic showed only a non-significant trend (-2.71 mmHg, P=0.077)
Reduced low-grade inflammation markers

View source

View in Research Library

Aronia Research

Mostly mechanism / observational

Impact of a Chokeberry (Aronia melanocarpa) Supplementation on Cardiometabolic Outcomes: A Critical Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Effects of Aronia melanocarpa on Cardiometabolic Diseases: A Systematic Review of Quasi-Design Studies and Randomized Controlled Trials.

Daily supplementation with aronia melanocarpa (chokeberry) reduces blood pressure and cholesterol: a meta analysis of controlled clinical trials.

Consumption of chokeberry (Aronia mitschurinii) products modestly lowered blood pressure and reduced low-grade inflammation in patients with mildly elevated blood pressure.